A1AFS - Overview: Alpha-1-Antitrypsin Clearance, Feces and Serum
Diagnosing protein-losing enteropathies
BOB1 - Overview: BOB-1 Immunostain, Technical Component Only
Classification of lymphomas
CLAUD - Overview: Claudin-1 Immunostain, Technical Component Only
Identification of a number of different soft tissue and epithelial neoplasms
DOG1 - Overview: DOG-1 Immunostain, Technical Component Only
Identification of gastrointestinal stromal tumors
GLUT - Overview: GLUT-1 Immunostain, Technical Component Only
Identification of erythrocytes in various normal and neoplastic tissues
FLI1 - Overview: FLI-1 Immunostain, Technical Component Only
Aiding in phenotyping endothelial-derived tumors, Ewing sarcoma, Merkel cell carcinoma, lung adenocarcinoma, melanoma, and erythroleukemia
ISLET - Overview: Islet 1 Immunostain, Technical Component Only
Identification of endocrine tumors
NEUD1 - Overview: Neuronal Differentiation 1 (NeuroD1), Technical Component only
Subclassification of small cell lung carcinoma
SF1 - Overview: SF-1 Immunostain, Technical Component Only
Classification of pituitary adenomas
PIT1 - Overview: PIT-1 Immunostain, Technical Component Only
Classification of pituitary adenomas
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.